Home
About Us
Company Profile
Corporate Culture
Platforms
Platform Overview
YTConju™ ADC Platform
YTConju™ AOC Platform
YTConju™ APC Platform
Products and Services
Early-stage R&D services
Licensing and Co-development
Site-Specific Glyco-editing Based Conjugation Kit
News
Partnership
Contact Us
Join Us
CN
EN
CN
Home
About Us
Company Profile
Corporate Culture
Platforms
Platform Overview
YTConju™ ADC Platform
YTConju™ AOC Platform
YTConju™ APC Platform
Products and Services
Early-stage R&D services
Licensing and Co-development
Site-Specific Glyco-editing Based Conjugation Kit
News
Contact Us
Join Us
Home
News
Academic Research
Angew Chem: Trimming Crystallizable Fragment (Fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies as Therapeutics
Time:2023.08.09
Source:Glyco-therapy
Link to original article: https://doi.org/10.1002/anie.202308174
Previous Article:None
Next Article:Antibody-Peptide Conjugates: Expanding New Approaches in Cancer Immunotherapy
Return to list